A randomized study of losartan vs propranolol: Effects on hepatic and systemic hemodynamics in cirrhotic patients

Background & aims: The potential use of losartan, an angiotensin II type 1 receptor blocker, in the treatment of portal hypertension is still under debate. This randomized controlled trial compared the effects of losartan vs. propranolol on portal and systemic hemodynamics in patients with c...

Full description

Bibliographic Details
Main Authors: Gustavo Castaño, Pedro Viudez, Miguel Riccitelli, Silvia Sookoian
Format: Article
Language:English
Published: Elsevier 2003-01-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119321568